ANL 34.25 Increased By ▲ 0.61 (1.81%)
ASC 13.35 Decreased By ▼ -0.05 (-0.37%)
ASL 22.60 Increased By ▲ 0.10 (0.44%)
AVN 83.70 Decreased By ▼ -0.74 (-0.88%)
BOP 7.70 Increased By ▲ 0.05 (0.65%)
BYCO 9.37 Decreased By ▼ -0.01 (-0.11%)
DGKC 110.20 Increased By ▲ 0.52 (0.47%)
EPCL 50.89 Increased By ▲ 0.64 (1.27%)
FCCL 22.76 Decreased By ▼ -0.02 (-0.09%)
FFBL 25.70 Increased By ▲ 0.09 (0.35%)
FFL 15.30 No Change ▼ 0.00 (0%)
HASCOL 9.00 Decreased By ▼ -0.04 (-0.44%)
HUBC 79.00 Increased By ▲ 4.80 (6.47%)
HUMNL 5.84 Decreased By ▼ -0.04 (-0.68%)
JSCL 18.70 Increased By ▲ 0.50 (2.75%)
KAPCO 39.39 Increased By ▲ 1.38 (3.63%)
KEL 3.68 Increased By ▲ 0.09 (2.51%)
LOTCHEM 14.35 Increased By ▲ 0.25 (1.77%)
MLCF 42.30 Increased By ▲ 0.05 (0.12%)
PAEL 31.07 Increased By ▲ 0.07 (0.23%)
PIBTL 9.45 Increased By ▲ 0.13 (1.39%)
POWER 8.44 Increased By ▲ 0.22 (2.68%)
PPL 83.30 Increased By ▲ 1.80 (2.21%)
PRL 22.77 Increased By ▲ 0.23 (1.02%)
PTC 9.20 Increased By ▲ 0.16 (1.77%)
SILK 1.40 Increased By ▲ 0.03 (2.19%)
SNGP 38.59 Increased By ▲ 0.49 (1.29%)
TRG 163.22 Decreased By ▼ -5.12 (-3.04%)
UNITY 34.93 Increased By ▲ 0.47 (1.36%)
WTL 1.45 Decreased By ▼ -0.04 (-2.68%)
BR100 4,799 Increased By ▲ 39.91 (0.84%)
BR30 24,693 Increased By ▲ 286.81 (1.18%)
KSE100 44,944 Increased By ▲ 380.02 (0.85%)
KSE30 18,383 Increased By ▲ 122.64 (0.67%)

Coronavirus
VERY HIGH
Pakistan Deaths
18,429
11924hr
Pakistan Cases
841,636
411324hr
Sindh
287,643
Punjab
310,616
Balochistan
22,776
Islamabad
76,696
KPK
121,099
Business & Finance

EU regulator starts real-time review of Moderna's COVID-19 vaccine candidate

  • The European Medicines Agency's human medicines committee has started a "rolling review" of Moderna's mRNA-1273 vaccine candidate and is evaluating the first batch of data.
  • EMA's announcement comes a week after Switzerland began a real-time review of data from Moderna's vaccine candidate.
16 Nov 2020

Europe's health regulator said on Monday it had launched a real-time review of US drugmaker Moderna Inc's experimental COVID-19 vaccine, following similar such reviews of rival vaccines from AstraZeneca and Pfizer.

The European Medicines Agency's human medicines committee has started a "rolling review" of Moderna's mRNA-1273 vaccine candidate and is evaluating the first batch of data, the regulator said.

Rolling reviews allow drug companies to submit applications for COVID-19 medicinal products before development work is concluded and prior to the availability of complete supporting documentation, aimed at speeding up any approval process.

In October, Moderna had said it would apply for real-time reviews of its vaccine in Europe.

EMA's announcement comes a week after Switzerland began a real-time review of data from Moderna's vaccine candidate.

Moderna said earlier this month that it has enough data for a first interim analysis of its late-stage COVID-19 vaccine trial.